Literature DB >> 9241551

Raised prostate-specific antigen in adenocarcinoma of the colon.

M Yamamoto1, H Hibi, K Miyake.   

Abstract

Serum prostate-specific antigen (PSA) values above 10 ng/ml are considered highly sensitive and specific for prostatic carcinoma in the absence of prostatic inflammation or trauma. However, in rare instances, non-prostatic malignancies have also been associated with raised serum PSA values. We have encountered a patient with increased serum PSA concentration measured by monoclonal antibody assay who had no evidence of prostatic malignant involvement, but suffered from colon cancer. Before operation for colon cancer his PSA was always over 30 ng/ml on several examinations. After total removal of colon cancer serum PSA level fell down to 1.2 ng/ml. Although immunohistochemical staining of colon cancer with monoclonal PSA antibody was not performed, some relationship between raised PSA and colon cancer is strongly suspected. Substances like serine protease which can cross-react with the PSA antibody might be produced by malignant tumour of non-prostatic origin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241551     DOI: 10.1007/bf02551345

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  Raised prostate-specific antigen in adenocarcinoma of lung.

Authors:  S Bilgrami; N T Singh; N Shafi; T Ciesielski
Journal:  Lancet       Date:  1994-11-12       Impact factor: 79.321

2.  Human prostate-specific antigen: structural and functional similarity with serine proteases.

Authors:  K W Watt; P J Lee; T M'Timkulu; W P Chan; R Loor
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.

Authors:  C J Ercole; P H Lange; M Mathisen; R K Chiou; P K Reddy; R L Vessella
Journal:  J Urol       Date:  1987-11       Impact factor: 7.450

4.  Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.

Authors:  M A Ferro; I Barnes; J B Roberts; P J Smith
Journal:  Br J Urol       Date:  1987-07

5.  Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Authors:  A W Partin; H B Carter; D W Chan; J I Epstein; J E Oesterling; R C Rock; J P Weber; P C Walsh
Journal:  J Urol       Date:  1990-04       Impact factor: 7.450

6.  Elevated prostate markers in metastatic small cell carcinoma of unknown primary.

Authors:  N J Freeman; C Doolittle
Journal:  Cancer       Date:  1991-09-01       Impact factor: 6.860

7.  Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.

Authors:  J H van Krieken
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

8.  False positive prostate specific antigen values in the sera of women with renal cell carcinoma.

Authors:  K Pummer; G Wirnsberger; P Pürstner; H Stettner; G Wandschneider
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

9.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

10.  Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.

Authors:  J Morote Robles; A Ruibal Morell; J Palou Redorta; J A de Torres Mateos; A Soler Roselló
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

View more
  3 in total

Review 1.  Reconnoitring the status of prostate specific antigen and its role in women.

Authors:  Prakruti Dash
Journal:  Indian J Clin Biochem       Date:  2014-06-22

2.  Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma.

Authors:  N Duraker; D Can; M Parilti
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

3.  Diagnostic Value of Combinatorial Markers in Colorectal Carcinoma.

Authors:  Veronika Voronova; Peter Glybochko; Andrey Svistunov; Viktor Fomin; Philipp Kopylov; Peter Tzarkov; Alexey Egorov; Evgenij Gitel; Aligeydar Ragimov; Alexander Boroda; Elena Poddubskaya; Marina Sekacheva
Journal:  Front Oncol       Date:  2020-05-22       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.